BG Bunge Global SA
Fats & Oils · NYSE · SEC CIK 1996862 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY55.5%
TTM net income YoY-12.4%
TTM EPS YoY-36.0%
Revenue 3-yr CAGR15.1%
Net income 3-yr CAGR-16.1%
Margins
Gross margin5.1%
Operating margin—
Net margin1.2%
FCF margin-2.8%
EBITDA margin—
Returns
ROE7.2%
ROA2.4%
ROIC (approx.)—
Asset turnover1.95x
Leverage & solvency
Liabilities / assets64.0%
Debt / equity1.03x
Current ratio1.50x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-0.82x
Accruals ratio4.4%
Payout ratio47.4%
Capex / revenue1.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $70.33B | $53.11B | $59.54B | $67.23B | $59.15B |
| Cost of revenue | $66.92B | $49.72B | $54.70B | $63.55B | $55.79B |
| Gross profit | $3.41B | $3.39B | $4.84B | $3.68B | $3.36B |
| R&D expense | $28.00M | $30.00M | $35.00M | $33.00M | $33.00M |
| SG&A expense | $2.11B | $1.78B | $1.72B | $1.37B | $1.23B |
| Interest expense | $628.00M | $471.00M | $516.00M | $403.00M | $243.00M |
| Pretax income | $1.13B | $1.52B | $3.05B | $2.07B | $2.56B |
| Income tax | $288.00M | $336.00M | $714.00M | $388.00M | $398.00M |
| Net income | $816.00M | $1.14B | $2.24B | $1.61B | $2.08B |
| EPS (basic) | 4.95 | 8.09 | 15.07 | 10.83 | 14.50 |
| EPS (diluted) | 4.91 | 7.99 | 14.87 | 10.51 | 13.64 |
| Dividends declared per share | 2.80 | 2.72 | 2.61 | 2.40 | 2.08 |
| Weighted avg. shares (diluted) | 166.47M | 142.22M | 150.79M | 153.13M | 152.37M |
| Balance sheet | |||||
| Cash & equivalents | $1.14B | $3.33B | $2.60B | $1.15B | $905.00M |
| Short-term investments | $861.00M | $484.00M | $105.00M | $119.00M | — |
| Receivables | $3.87B | $2.15B | $2.59B | $2.83B | — |
| Inventory | $13.20B | $6.49B | $7.11B | $8.41B | — |
| Current assets | $24.39B | $15.96B | $16.35B | $16.76B | — |
| PP&E, net | $11.68B | $5.25B | $4.54B | $3.62B | — |
| Goodwill | $3.14B | $453.00M | $489.00M | $470.00M | — |
| Intangibles | $309.00M | $321.00M | $398.00M | $360.00M | — |
| Total assets | $44.53B | $24.90B | $25.37B | $24.58B | $23.82B |
| Current liabilities | $15.13B | $7.43B | $7.69B | $9.60B | — |
| Short-term debt | $5.22B | $1.54B | $802.00M | $846.00M | — |
| Long-term debt | $8.83B | $4.69B | $4.08B | $3.26B | — |
| Total debt | $14.05B | $6.24B | $4.88B | $4.11B | — |
| Total liabilities | $27.11B | $13.95B | $13.56B | $14.62B | — |
| Shareholders' equity | $15.90B | $9.91B | $10.85B | $9.22B | $7.83B |
| Net debt | $12.92B | $2.91B | $2.28B | $2.95B | — |
| Cash flow statement | |||||
| Operating cash flow | $844.00M | $1.90B | $3.31B | -$5.55B | -$2.89B |
| Capital expenditure | $1.72B | $1.38B | $1.12B | $555.00M | $399.00M |
| Free cash flow | -$879.00M | $524.00M | $2.19B | -$6.10B | -$3.29B |
| Investing cash flow | -$5.23B | -$1.11B | -$1.01B | $6.50B | $5.11B |
| Financing cash flow | $2.23B | -$90.00M | -$856.00M | -$769.00M | -$1.63B |
| Depreciation & amortization | $703.00M | $468.00M | $451.00M | $408.00M | $424.00M |
| Stock-based compensation | $73.00M | $65.00M | $69.00M | $65.00M | $61.00M |
| Dividends paid | $459.00M | $378.00M | $383.00M | $349.00M | $289.00M |
| Share buybacks | $551.00M | $1.10B | $600.00M | $200.00M | $100.00M |
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.